Snowflake Score | |
---|---|
Valuation | 4/6 |
Future Growth | 1/6 |
Past Performance | 0/6 |
Financial Health | 2/6 |
Dividends | 0/6 |
Curaleaf Holdings, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CA$6.98 |
52 Week High | CA$8.73 |
52 Week Low | CA$3.45 |
Beta | 1.55 |
1 Month Change | 5.44% |
3 Month Change | 0.87% |
1 Year Change | 81.30% |
3 Year Change | -60.79% |
5 Year Change | -44.29% |
Change since IPO | -18.55% |
Recent News & Updates
Recent updates
Subdued Growth No Barrier To Curaleaf Holdings, Inc. (TSE:CURA) With Shares Advancing 25%
Jan 19Does Curaleaf Holdings (CSE:CURA) Have A Healthy Balance Sheet?
Dec 11Is Curaleaf Holdings (CSE:CURA) Using Too Much Debt?
Sep 08Curaleaf Holdings (CSE:CURA) Has Debt But No Earnings; Should You Worry?
May 28We Think Curaleaf Holdings (CSE:CURA) Is Taking Some Risk With Its Debt
Sep 05Here's Why Curaleaf Holdings (CSE:CURA) Has A Meaningful Debt Burden
May 20Is Curaleaf Holdings (CSE:CURA) A Risky Investment?
Oct 26Loss-Making Curaleaf Holdings, Inc. (CSE:CURA) Set To Breakeven
Mar 20Is Curaleaf Holdings' (CSE:CURA) Share Price Gain Of 188% Well Earned?
Feb 27Calculating The Fair Value Of Curaleaf Holdings, Inc. (CSE:CURA)
Feb 01Curaleaf Holdings (CSE:CURA) Has A Somewhat Strained Balance Sheet
Jan 11Shareholder Returns
CURA | CA Pharmaceuticals | CA Market | |
---|---|---|---|
7D | -10.3% | -5.6% | 0.3% |
1Y | 81.3% | 50.3% | 12.5% |
Return vs Industry: CURA exceeded the Canadian Pharmaceuticals industry which returned 55.7% over the past year.
Return vs Market: CURA exceeded the Canadian Market which returned 11.8% over the past year.
Price Volatility
CURA volatility | |
---|---|
CURA Average Weekly Movement | 13.5% |
Pharmaceuticals Industry Average Movement | 14.2% |
Market Average Movement | 8.9% |
10% most volatile stocks in CA Market | 17.9% |
10% least volatile stocks in CA Market | 2.9% |
Stable Share Price: CURA's share price has been volatile over the past 3 months.
Volatility Over Time: CURA's weekly volatility (13%) has been stable over the past year, but is still higher than 75% of Canadian stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
n/a | 5,650 | Matt Darin | www.curaleaf.com |
Curaleaf Holdings, Inc. operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles.
Curaleaf Holdings, Inc. Fundamentals Summary
CURA fundamental statistics | |
---|---|
Market cap | CA$5.29b |
Earnings (TTM) | -CA$324.32m |
Revenue (TTM) | CA$1.85b |
2.8x
P/S Ratio-16.0x
P/E RatioIs CURA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
CURA income statement (TTM) | |
---|---|
Revenue | US$1.35b |
Cost of Revenue | US$738.01m |
Gross Profit | US$614.91m |
Other Expenses | US$851.82m |
Earnings | -US$236.90m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -0.32 |
Gross Margin | 45.45% |
Net Profit Margin | -17.51% |
Debt/Equity Ratio | 51.1% |
How did CURA perform over the long term?
See historical performance and comparison